Skeletal muscle cells lacking the retinoblastoma protein display defects in muscle gene expression and accumulate in S and G2 phases of the cell cycle

Journal of Cell Biology

Volumn 135, Issue 2, 1996, Pages 441-456

  Novitch, Bennett G ^a   Mulligan, George J ^b   Jacks, Tyler ^b   Lassar, Andrew B ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN A; CYCLIN B; CYCLIN DEPENDENT KINASE; MYOGENIN; MYOSIN HEAVY CHAIN; PROTEIN KINASE; PROTEIN P21; RETINOBLASTOMA PROTEIN;

ANIMAL CELL; ARTICLE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL DIFFERENTIATION; DNA SYNTHESIS INHIBITION; EMBRYO; GENE EXPRESSION; MITOSIS INHIBITION; MOUSE; MUSCLE CELL; MUSCLE DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL; SKELETAL MUSCLE;

ANIMALS; CAFFEINE; CDC2 PROTEIN KINASE; CELL CYCLE; CELL DIFFERENTIATION; CELLS, CULTURED; CHLORAMPHENICOL O-ACETYLTRANSFERASE; CYCLINS; DNA; EMBRYO; FIBROBLASTS; G2 PHASE; MICE; MICE, KNOCKOUT; MICE, MUTANT STRAINS; MUSCLE, SKELETAL; MYOD PROTEIN; MYOGENIN; MYOSIN HEAVY CHAINS; PHOSPHORYLATION; RECOMBINANT FUSION PROTEINS; RETINOBLASTOMA PROTEIN; S PHASE; THYMIDINE KINASE; TRANSFECTION;

ANIMALIA;

EID: 0029960519     PISSN: 00219525     EISSN: None     Source Type: Journal    
DOI: 10.1083/jcb.135.2.441     Document Type: Article

References (111)

1. Adamo, S., B. Zani, G. Siracusa, and M. Molinaro. 1973. Expression of differentiative traits in the absence of cell fusion during myogenesis in culture. Cell Differ. 5:53-67.
2. Amacher, S., J. Buskin, and S. Hauschka. 1993. Multiple regulatory elements contribute differentially to muscle creatine kinase enhancer activity in skeletal and cardiac muscle. Mol. Cell. Biol. 13:2753-2764.
3. Andrés, V., and K. Walsh. 1996. Myogenin expression, cell cycle withdrawal, and phenotypic differentiation are temporally separable events that precede cell fusion upon myogenesis. J. Cell Biol. 132:657-666.
4. Bader, D., T. Masaki, and D.A. Fischman. 1982. Immunochemical analysis of myosin heavy chain during avian myogenesis in vivo and in vitro. J. Cell Biol. 95:763-770.
5. Benezra, R., R.L. Davis, D. Lockshon, D.L. Turner, and H. Weintraub. 1990. The protein id: a negative regulator of helix-loop-helix DNA binding proteins. Cell. 61:49-59.
6. Braun, T., E. Bober, and H.H. Arnold. 1992. Inhibition of muscle differentiation by the adenovirus E1A protein: repression of the transcriptional activating function of the HLH protein Myf-5. Genes Dev. 6:888-902.
7. Buckingham, M. 1992. Making muscle in mammals. Trends Genet. 8:144-149.
8. Cardoso, M.C., H. Leonhardt, and B. Nadal-Ginard. 1993. Reversal of terminal differentiation and control of DNA replication: cyclin A and cdk2 specifically localize at subnuclear sites of DNA replication. Cell. 74:979-992.
9. Caruso, M., F. Martelli, A. Giordano and A. Felsani. 1993. Regulation of MyoD gene transcription and protein function by the transforming domains of the adenovirus E1A oncoprotein. Oncogene. 8:267-278.
10. Chen, P.-L., D.J. Riley, S. Chen-Kiang, and W.-H. Lee. 1996. Retinoblastoma protein directly interacts with and activates the transcription factor NF-IL6. Proc. Natl. Acad. Sci. USA. 93:465-469.
11. Clarke, A.R., E.R. Maandag, M. van Roon, N.M.T. van der Lugt, M. van der Valk, M.L. Hooper, A. Berns, and H. te Riele. 1992. Requirement for a functional Rb-1 gene in murine development. Nature (Lond). 359:328-330.
12. Coleman, T.R., and W.G. Dunphy. 1994. Cdc2 regulatory factors. Curr. Opin. Cell Biol. 6:887-882.
13. Coppola, J.A., B.A. Lewis, and M.D. Cole. 1990. Increased retinoblastoma gene expression is associated with late stages of differentiation in many different cell types. Oncogene. 5:1731-1733.
14. Corbeil, H.B., P. Whyte, and P.E. Branton. 1995. Characterization of transcription factor E2F complexes during muscle and neuronal differentiation. Oncogene. 11:909-920.
15. Crescenzi, M., S. Soddu, and F. Tato. 1995. Mitotic cycle reactivation in terminally differentiated cells by adenovirus infection. J Cell. Phys. 162:26-35.
16. Cserjesi, P., and E.N. Olson. 1991. Myogenin induces the myocyte-specific enhancer binding factor MEF-2 independently of other muscle-specific gene products. Mol. Cell. Biol. 11:4854-4862.
17. Davis, R.L., H. Weintraub, and A.B. Lassar. 1987. Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell. 51:987-1000.
18. DeGregori, J., T. Kowalik, and J.R. Nevins. 1995a. Cellular targets for activation by the E2F1 transcription factor include DNA synthesis- and G(1)/S-regulatory genes. Mol. Cell. Biol. 15:4215-4224.
19. DeGregori, J., G. Leone, K. Ohtani, A. Miron, and J.R. Nevins. 1995b. E2F-1 accumulation bypasses a G1 arrest resulting from inhibition of G1 cyclin-dependent kinase activity. Genes Dev. 9:2873-2887.
20. Emerson, C.P. 1993. Skeletal myogenesis: genetics and embryology to the fore. Curr. Opin. Genet. Dev. 3:265-274.
21. Endo, T. 1992. SV40 large T inhibits myogenic differentiation partially through inducing c-jun. J. Biochem. 112:321-329.
22. Endo, T., and S. Goto. 1992. Retinoblastoma gene product Rb accumulates during myogenic differentiation and is deinduced by the expression of SV40 large T antigen. J. Biochem. 112:427-430.
23. Endo, T., and B. Nadal-Ginard. 1989. SV40 large T antigen induces reentry of terminally differentiated myotubes into the cell cycle. In The Cellular and Molecular Biology of Muscle Development. L.H. Kedes and F. E. Stockdale, editors. A.R. Liss, Inc., New York. 95-104.
24. Enkemann, S.A., S.F. Konieczny, and E.J. Taparowsky. 1990. Adenovirus 5 E1A represses muscle-specific enhancers and inhibits expression of the myogenic regulatory factor genes, MyoD1 and Myogenin. Cell Growth Diff. 1:375-382.
25. Fogel, M., and V. Defendi. 1967. Infection of muscle cultures from various species with oncogenic DNA viruses (SV40 and polyoma). Proc. Natl. Acad. Sci. USA. 58:967-973.
26. Gorman, S.D., and V.J. Cristofalo. 1985. Reinitiation of cellular DNA synthesis in BrdU-selected nondividing senescent WI-38 cells by simian virus 40 infection. J. Cell Physiol. 125:122-126.
27. Graessmann, A., M. Graessmann, and M. Fogel. 1973. The relationship of polyoma virus-induced tumor (T) antigen to activation of DNA synthesis in rat myotubes. Dev. Biol. 35:180-186.
28. Gu, W., J.W. Schneider, G. Condorelli, S. Kaushal, V. Mahdavi, and B. Nadal-Ginard. 1993a. Interaction of myogenic factors and the retinoblastoma protein mediates muscle cell commitment and differentiation. Cell. 72:309-324.
29. Gu, Y., C.W. Turck, and D.O. Morgan. 1993b. Inhibition of cdk2 activity in vivo by an associated 20K regulatory subunit. Nature (Lond.). 366:707-710.
30. Guadagno, T.M., and J.W. Newport. 1996. Cdk2 kinase is required for entry into mitosis as a positive regulator of Cdc2-cyclin B kinase activity. Cell. 84: 73-82.
31. INK4/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function. Genes Dev. 8:2939-2952.
32. Gunning, P., E. Hardeman, R. Wade, P. Ponte, W. Bains, H.M. Blau, and L. Kedes. 1987. Differential patterns of transcript accumulation during human myogenesis. Mol. Cell. Biol. 7:4100-4114.
33. Guo, K., J. Wang, V. Andrés, R.C. Smith, and K. Walsh. 1995. MyoD-induced expression of p21 inhibits cyclin-dependent kinase activity upon myocyte terminal differentiation. Mol. Cell. Biol. 15:3823-3829.
34. Halevy, O., B.G. Novitch, D.B. Spicer, S.X. Skapek, J. Rhee, G.J. Hannon, D. Beach, and A.B. Lassar. 1995. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science (Wash. DC). 267: 1018-1021.
35. Hardy, S., Y. Kong, and S.F. Konieczny. 1993. Fibroblast growth factor inhibits MRF4 activity independently of the phosphorylation status of a conserved threonine residue within the DNA-binding domain. Mol. Cell. Biol. 13:5943-5956.
36. Harper, J., G. Adami, N. Wei, K. Keyomarsi, and S. Elledge. 1993. The p21 cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell. 75:805-816.
37. Heald, R., M. McLoughlin, and F. McKeon. 1993. Human wee1 maintains mitotic timing by protecting the nucleus from cytoplasmically activated Cdc2 kinase. Cell. 74:463-474.
38. Hollenberg, S.M., P.F. Cheng, and H. Weintraub. 1993. Use of a conditional MyoD transcription factor in studies of MyoD trans-activation and muscle differentiation. Proc. Natl. Acad. Sci. USA. 90:8028-8032.
39. Iujvidin, S., O. Fuchs, U. Nudel, and D. Yaffe. 1990. SV40 immortalizes myogenic cells: DNA synthesis and mitosis in differentiating myotubes. Differentiation. 43:192-203.
40. Jacks, T., A. Fazeli, E.M. Schmitt, R.T. Bronson, M.A. Goodell, and R.A. Weinberg. 1992. Effects of an Rb mutation in the mouse. Nature (Lond.). 359:295-300.
41. Jahn, L., J. Sadoshima, and S. Izumo. 1994. Cyclins and cyclin-dependent kinases are differentially regulated during terminal differentiation of C2C12 muscle cells. Exp. Cell Res. 212:297-307.
42. Jaynes, J., J. Johnson, J. Buskin, C. Gartside, and S. Hauschka. 1988. The muscle creatine kinase gene is regulated by multiple upstream elements, including a muscle-specific enhancer. Mol. Cell. Biol 8:62-70.
43. Jen, Y., H. Weintraub, and R. Benezra. 1992. Overexpression of Id protein inhibits the muscle differentiation program: in vivo association of Id with E2A proteins. Genes Dev. 6:1466-1479.
44. Johnson, D.G., J.K. Schwarz, W.D. Cress, and J.R. Nevins. 1993. Expression of the transcription factor E2F1 induces quiescent cells to enter S phase. Nature (Lond.). 365:349-352.
45. Kiess, M., R.M. Gill, and P.A. Hamel. 1995a. Expression and activity of the retinoblastoma protein (pRb)-family Proteins, p107 and p130, during L(6) myoblast differentiation. Cell Growth Diff. 6:1287-1298.
46. Kiess, M., R.M. Gill, and P.A. Hamel. 1995b. Expression of the positive regulator of cell cycle progression, cyclin D3, is induced during differentiation of myoblasts into quiescent myotubes. Oncogene. 10:159-166.
47. King, R.W., P.K. Jackson, and M.W. Kirschner. 1994. Mitosis in transition. Cell. 79:563-571.
48. Koh, J., G.H. Enders, B.D. Dynlacht, and E. Harlow. 1995. Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibition. Nature (Lond.). 375:506-510.
49. Krek, W., M.E. Ewen, S. Shirodkar, Z. Arany, W.G. Kaelin, and D.M. Livingston. 1994. Negative regulation of the growth-promoting transcription factor E2F-1 by a stably bound cyclin A-dependent protein kinase. Cell. 78:161-172.
50. Krek, W., G. Xu, and D.M. Livingston. 1995. Cyclin A-kinase regulation of E2F-1 DNA binding function underlies suppression of an S phase checkpoint. Cell. 83:1149-1158.
51. Lassar, A.B., and A. Münsterberg. 1994. Wiring diagrams: regulatory circuits and the control of skeletal myogenesis. Curr. Opin. Cell Biol. 6:432-442.
52. Lassar, A.B., S.X. Skapek, and B. Novitch. 1994. Regulatory mechanisms that coordinate skeletal muscle differentiation and cell cycle withdrawal. Curr. Opin. Cell Biol. 6:788-794.
53. Lee, E.Y.-H.P., C.-Y. Chang, N. Hu, Y.-C.J. Wang, C.-C. Lai, K. Herrup, W.-H. Lee, and A. Bradley. 1992. Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis. Nature (Lond.). 359:288-294.
54. Lee, E.Y.-H.P., N. Hu, S.F. Yuan, L.A. Cox, A. Bradley, W.-H. Lee, and K. Herrup. 1994. Dual roles of the retinoblastoma protein in cell cycle regulation and neuron differentiation. Genes Dev. 8:2008-2021.
55. KIP2, a cyclin-dependent kinase inhibitor with unique domain structure, and tissue distribution. Genes Dev. 9:639-649.
56. Li, L., J. Zhou, G. James, R. Heller-Harrison, M.P. Czech, and E.N. Olson. 1992. FGF inactivates myogenic helix-loop-helix proteins through phosphorylation of a conserved protein kinase C site in their DNA-binding domains. Cell. 71:1181-1194.
57. Lin, Z., M.-H. Lu, T. Schultheiss, J. Choi, S. Holtzer, C. DiLullo, D.A. Fischman, and H. Holtzer. 1994. Sequential appearance of muscle-specific proteins in myoblasts as a function of time after cell division: evidence for a conserved myoblast differentiation program in skeletal muscle. Cell Motil. Cytoskeleton. 29:1-19.
58. Lukas, J., D. Parry, L. Aagaard, D.J. Mann, J. Bartkova, M. Strauss, G. Peters, and J. Bartek. 1995. Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16. Nature (Lond.). 375:503-506.
59. Martelli, F., C. Cenciarelli, G. Santarelli, B. Polikar, A. Felsani, and M. Caruso. 1994. MyoD induces retinoblastoma gene expression during myogenic differentiation. Oncogene. 9:3579-3590.
60. (CIP1) CDK inhibitor family, is a candidate tumor suppressor gene. Genes Dev. 9:650-662.
61. ink4 requires functional retinoblastoma protein. Proc. Natl. Acad. Sci. USA. 92:6289-6293.
62. Missero, C., E. Calautti, R. Eckner, J. Chin, L.H. Tsai, D.M. Livingston, and G.P. Dotto. 1995. Involvement of the cell-cycle inhibitor Cip1/WAF1 and the E1A-associated p300 protein in terminal differentiation. Proc. Natl. Acad. Sci. USA. 92:5451-5455.
63. Moran, E. 1993. DNA tumor virus transforming proteins and the cell cycle. Curr. Opin. Genet. Dev. 3:63-70.
64. Morgenbesser, S.D., B.O. Williams, T. Jacks, and R.A. DePinho. 1994. p53-dependent apoptosis produced by Rb-deficiency in the developing mouse lens. Nature (Lond.). 371:72-74.
65. Morgenstern, J.P., and H. Land. 1990. Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids. Res. 18:3587-3596.
66. Müller, R. 1995. Transcriptional regulation through the cell cycle. Trends Genet. 11:173-178.
67. Mulligan, R.C., and P. Berg. 1981. Selection for animal cells that express the Escherichia coli gene coding for xanthine-guanine phosphoribosyltransferase. Proc. Natl. Acad. Sci. USA. 78:2072-2076.
68. 3H1 myoblasts correlates with their binding to a 300 kD cellular protein. Mol. Biol. Cell. 3:1107-1115.
69. Noda, A., Y. Ning, S.F. Venable, O.M. Pereira-Smith, and J.R. Smith. 1994. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp. Cell Res. 211:90-98.
70. Nurse, P. 1994. Ordering S phase and M phase in the cell cycle. Cell. 79:547-550.
71. Ohkubo, Y., T. Kishimoto, T. Nakata, H. Yasuda, and T. Endo. 1994. SV40 large T antigen reinduces the cell cycle in terminally differentiated myotubes through inducing Cdk2, Cdc2, and their partner cyclins. Exp. Cell Res. 214: 270-278.
72. Ohtani, K., J. DeGregori, and J.R. Nevins. 1995. Regulation of the cyclin E gene by transcription factor E2F1. Proc. Natl. Acad. Sci. USA. 92:12146-12150.
73. Olson, E.N., and W.H. Klein. 1994. bHLH factors in muscle development: dead lines and commitments, what to leave in and what to leave out. Genes Dev. 8:1-8.
74. Pagano, M., R. Pepperkok, F. Verde, W. Ansorgc, and G. Draetta. 1992. Cyclin A is required at two points in the human cell cycle. EMBO (Eur. Mol. Biol. Organ.) J. 11:961-971.
75. Parker, S.B., G. Eichele, P. Zhang, A. Rawls, A.T. Sands, A. Bradley, E.N. Olson, J.W. Harper, and S.J. Elledge. 1995. p53-independent expression of p21Cip1 in muscle and other terminally differentiating cells. Science (Wash. DC). 267:1024-1027.
76. Pear, W.S., G.P. Nolan, M.L. Scott, and D. Baltimore. 1993. Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl. Acad. Sci. USA. 90:8392-8396.
77. Pines, J., and T. Hunter. 1991. Human cyclins A and B1 are differentially located in the cell and undergo cell cycle-dependent nuclear transport. J. Cell. Biol. 115:1-17.
78. Qin, X.-O., T. Chittenden, D. Livingston, and W.G. Kaelin. 1992. Identification of a growth suppression domain within the retinoblastoma gene product. Genes Dev. 6:953-964.
79. Qin, X.-Q., D.M. Livingston, W.G. Kaelin, and P.D. Adams. 1994. Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis. Proc. Natl. Acad. Sci. USA. 91:10918-10922.
80. Rao, S.S., C. Chu, and D.S. Kohtz. 1994. Ectopic expression of cyclin D1 prevents activation of gene transcription by myogenic basic helix-loop-helix regulators. Mol. Cell. Biol. 14:5259-5267.
81. Rao, S.S., and D.S. Kohtz. 1995. Positive and negative regulation of D-type cyclin expression in skeletal myoblasts by basic fibroblast factor beta. A role for cyclin D1 in control of myoblast differentiation. J. Biol. Chem. 270:4093-4100.
82. Robertson, E.J. 1987. Embryo-derived stem cell lines. In Teratocarcinomas and Embryonic Stem Cells. E.J. Robertson, editor. IRL Press, Oxford, UK 71-112.
83. Sassoon, D.A. 1993. Myogenic regulatory factors: dissecting their role and regulation during vertebrate embryogenesis. Dev. Biol. 156:11-23.
84. Schlegel, R., and A.B. Pardee. 1986. Caffeine-induced uncoupling of mitosis from the completion of DNA replication in mammalian cells. Science (Wash. DC). 232:1264-1266.
85. Schneider, J.W., W. Gu, L. Zhu, V. Mahdavi, and B. Nadal-Ginard. 1994. Reversal of terminal differentiation mediated by p107 in Rb-/- muscle cells. Science (Wash. DC). 264:1467-1471.
86. Serrano, M., G. Hannon, and D. Beach. 1993. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature (Lond.). 366:704-707.
87. Shan, B., and W. Lee. 1994. Deregulated expression of E2F-1 induces S-phase entry and leads to apoptosis. Mol. Cell. Biol. 14:8166-8173.
88. Sherr, C.J. 1994a. G1 phase progression: cycling on cue. Cell. 79:551-555.
89. Sherr, C.J. 1994b. The ins and outs of RB: coupling gene expression to the cell cycle clock. Trends Cell Biol. 4:15-18.
90. Shin, E.K., A. Shin, C. Paulding, B. Schaffhausen, and A.S. Yee. 1995. Multiple changes in E2F function and regulation occur upon muscle differentiation. Mol. Cell. Biol. 15:2252-2262.
91. Skapek, S.X., J. Rhee, D.B. Spicer, and A.B. Lassar. 1995. Inhibition of myogenic differentiation in proliferating myoblasts by cyclin D1-dependent kinase. Science (Wash. DC). 267:1022-1024.
92. cdc2. Cell. 68:787-797.
93. cdc2/Cyclin B complex formation. Proc. Natl. Acad. Sci. USA. 88:6843-6847.
94. Tapscott, S.J., R.L. Davis, M.J. Thayer, P.-F. Cheng, H. Weintraub, and A.B. Lassar. 1988. MyoD1: a nuclear phosphoprotein requiring a Myc homology region to convert fibroblasts to myoblasts. Science (Wash. DC). 242:405-411.
95. 12S and basic helix-loop-helix proteins. Mol. Cell. Biol. 13: 4714-4727.
96. Tedesco, D., M. Caruso, L. Fischer-Fantuzzi, and C. Vesco. 1995. The inhibition of cultured myoblast differentiation by the simian virus 40 large T antigen occurs after myogenin expression and Rb up-regulation and is not exerted by transformation-competent cytoplasmic mutants. J. Virol. 69:6947-6957.
97. Thorburn, A.M., P.A. Walton, and J.R. Feramisco. 1993. MyoD induced cell cycle arrest is associated with increased nuclear affinity of the Rb protein. Mol. Biol. Cell. 4:705-713.
98. Toyoshima, H., and T. Hunter. 1994. p27, a novel inhibitor of G1 cyclin-cdk protein kinase activity, is related to p21. Cell. 78:67-74.
99. Vairo, G., D.M. Livingston, and D. Ginsberg. 1995. Functional interaction between E2F-4 and p130: evidence for distinct mechanisms underlying growth suppression by different retinoblastoma protein family members. Genes Dev. 9:869-881.
100. Walker, D.H., and J.L. Maller. 1991. Role for cyclin A in the dependence of mitosis on completion of DNA replication. Nature (Lond.). 354:314-317.
101. Wang, J., and B. Nadal-Ginard. 1995. Regulation of cyclins and p34CDC2 expression during terminal differentiation of C2C12 myocytes. Biochem. Biophys. Res. Commun. 206:82-88.
102. Webster, K.A., G.E.O. Muscat, and L. Kedes. 1988. Adenovirus E1A products suppress myogenic differentiation and inhibit transcription from muscle-specific promoters. Nature (Lond.). 332:553-557.
103. Weinberg, R.A. 1995. The retinoblastoma protein and cell cycle control. Cell. 81:323-330.
104. Weintraub, H. 1993. The MyoD family and myogenesis: redundancy, networks, and thresholds. Cell 75: 1241-1244.
105. Weintraub, H., S.J. Tapscott, R.L. Davis, M.J. Thayer, M.A. Adam, A.B. Lassar, and A.D. Miller. 1989. Activation of muscle-specific genes in pigment, nerve, fat, liver, and fibroblast cell lines by forced expression of MyoD. Proc. Natl. Acad. Sci. USA. 86:5434-5438.
106. Weintraub, H., R. Davis, D. Lockshon, and A. Lassar. 1990. MyoD binds cooperatively to two sites in a target enhancer sequence: occupancy of two sites is required for activation. Proc. Natl. Acad. Sci. USA. 87:5623-5627.
107. Wright, W.E. 1992. Muscle basic helix-loop-helix proteins and the regulation of myogenesis. Curr. Opin. Genet. Dev. 2:243-248.
108. Xiong, Y., G. Hannon, H. Zhang, D. Casso, R. Kobayashi, and D. Beach. 1993. p21 is a universal inhibitor of cyclin kinases. Nature (Lond). 366:701-704.
109. Yaffe, D., and D. Gershon. 1967. Multinucleated muscle fibres: induction of DNA synthesis and mitosis by polyoma virus infection. Nature (Lond.). 215: 421-424.
110. Zalvide, J., and J.A. DeCaprio. 1995. Role of pRh-related proteins in simian virus 40 large-T-antigen-mediated transformation. Mol. Cell. Biol. 15:5800-5810.
111. Zhu, L., S. van den Heuvel, K. Helin, A. Fattaey, M. Ewen, D. Livingston, N. Dyson, and E. Harlow. 1993. Inhibition of cell proliferation by p107, a relative of the retinoblastoma protein. Genes Dev. 7:1111-1125.